tiprankstipranks
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market
CRBP
Corbus Pharmaceuticals
RESEARCH TOOLSreports
Want to see CRBP full AI Analyst Report?

Corbus Pharmaceuticals (CRBP) Stock News & Sentiment

2,552 Followers
MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts
Premium
Weekend Updates
MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts
8d ago
CLS
ELV
Corbus Pharmaceuticals Initiated at Buy on CRB-701 Head and Neck Cancer Opportunity, Undervalued Pipeline, and $45 Price Target
Premium
Ratings
Corbus Pharmaceuticals Initiated at Buy on CRB-701 Head and Neck Cancer Opportunity, Undervalued Pipeline, and $45 Price Target
11d ago
CRBP
Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections
Premium
Company Announcements
Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections
23d ago
8K
CRBP
Corbus Advances CANYON-1 Phase 1b Obesity Trial Milestone
Premium
Company Announcements
Corbus Advances CANYON-1 Phase 1b Obesity Trial Milestone
26d ago
8K
CRBP
Corbus Aligns With FDA on CRB-701 Registrational Path
Premium
Company Announcements
Corbus Aligns With FDA on CRB-701 Registrational Path
1M ago
8K
CRBP
3 Best Stocks to Buy Today, 4/3/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 4/3/2026, According to Top Analysts
1M ago
AVNW
CNTX
Corbus Pharmaceuticals: Advancing Best-in-Class Nectin-4 ADC and Emerging Obesity Franchise Support Buy Rating
Premium
Ratings
Corbus Pharmaceuticals: Advancing Best-in-Class Nectin-4 ADC and Emerging Obesity Franchise Support Buy Rating
2M ago
CRBP
More CRBP News >

CRBP News on the Web

Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections
TipRanks News
Neutral
Corbus Advances CANYON-1 Phase 1b Obesity Trial Milestone
TipRanks News
Neutral
Corbus Pharmaceuticals announces last person enrolled in CANYON-1 trial
TipRanks News
Bullish
Corbus Pharmaceuticals CANYON-1 Study Reaches Key Enrollment Milestone—CRB-913 Offers Potential Alternative for Obesity Treatment
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), Corbus Pharmaceuticals (CRBP) and Avita Medical (RCEL)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP), Armata Pharmaceuticals (ARMP) and Moderna (MRNA)
TipRanks News
Neutral
Corbus Pharmaceuticals (CRBP) Gets a Buy from Wedbush
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals (CRBP) and Artivion (AORT)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CRBP
Sector Average
Media Buzz
This Week4 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRBP’s Media Buzz Sentiment?
4 articles about CRBP were published this week. In an average week, 2.5 articles are published.
    What is CRBP’s weekly average amount of articles?
    In an average week, 2.5 articles about CRBP are published.
      What is CRBP’s News Sentiment?
      100% of articles about CRBP were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week